A citation-based method for searching scientific literature

Katarzyna Z Kuter, M Angela Cenci, Anna R Carta. Prog Brain Res 2020
Times Cited: 11







List of co-cited articles
104 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
David Tweedie, Ryan A Ferguson, Kelly Fishman, Kathryn A Frankola, Henriette Van Praag, Harold W Holloway, Weiming Luo, Yazhou Li, Luca Caracciolo, Isabella Russo,[...]. J Neuroinflammation 2012
144
36

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
27



Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
27


3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation.
Chih-Tung Lin, Daniela Lecca, Ling-Yu Yang, Weiming Luo, Michael T Scerba, David Tweedie, Pen-Sen Huang, Yoo-Jin Jung, Dong Seok Kim, Chih-Hao Yang,[...]. Elife 2020
17
27

Pomalidomide Reduces Ischemic Brain Injury in Rodents.
Yan-Rou Tsai, David Tweedie, Ignacio Navas-Enamorado, Michael T Scerba, Cheng-Fu Chang, Jing-Huei Lai, John Chung-Che Wu, Yen-Hua Chen, Shuo-Jhen Kang, Barry J Hoffer,[...]. Cell Transplant 2019
10
30

Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.
Eun-Jung Lee, Moon-Sook Woo, Pyong-Gon Moon, Moon-Chang Baek, In-Young Choi, Won-Ki Kim, Eunsung Junn, Hee-Sun Kim. J Immunol 2010
184
27

Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro.
Chris Mahony, Lynda Erskine, Jennifer Niven, Nigel H Greig, William Douglas Figg, Neil Vargesson. Proc Natl Acad Sci U S A 2013
44
27

In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
S Iannaccone, C Cerami, M Alessio, V Garibotto, A Panzacchi, S Olivieri, G Gelsomino, R M Moresco, D Perani. Parkinsonism Relat Disord 2013
136
27

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.
Giovanna Mulas, Elena Espa, Sandro Fenu, Saturnino Spiga, Giovanni Cossu, Elisabetta Pillai, Ezio Carboni, Gabriella Simbula, Dragana Jadžić, Fabrizio Angius,[...]. Exp Neurol 2016
53
27

Microglial activation and dopamine terminal loss in early Parkinson's disease.
Yasuomi Ouchi, Etsuji Yoshikawa, Yoshimoto Sekine, Masami Futatsubashi, Toshihiko Kanno, Tomomi Ogusu, Tatsuo Torizuka. Ann Neurol 2005
582
27

Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.
Xiao-Yan Qin, Shu-Ping Zhang, Chang Cao, Y Peng Loh, Yong Cheng. JAMA Neurol 2016
244
27


The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease.
Ronit Sharon, Ifat Bar-Joseph, Matthew P Frosch, Dominic M Walsh, James A Hamilton, Dennis J Selkoe. Neuron 2003
422
27

Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Giuliana Fusco, Ezio Carboni, Maria Antonietta Casu, Valentina Satta, Maria Scherma, Elzbieta Janda, Ignazia Mocci,[...]. Int J Mol Sci 2020
11
27

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Nour K Majbour, Nishant N Vaikath, Karin D van Dijk, Mustafa T Ardah, Shiji Varghese, Louise B Vesterager, Liliana P Montezinho, Stephen Poole, Bared Safieh-Garabedian, Takahiko Tokuda,[...]. Mol Neurodegener 2016
141
27

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
A L Moreira, E P Sampaio, A Zmuidzinas, P Frindt, K A Smith, G Kaplan. J Exp Med 1993
906
27

Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism.
Bogdan Brodacki, Jacek Staszewski, Beata Toczyłowska, Ewa Kozłowska, Nadzieja Drela, Małgorzata Chalimoniuk, Adam Stepien. Neurosci Lett 2008
179
27

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
Paul Edison, Imtiaz Ahmed, Zhen Fan, Rainer Hinz, Giorgio Gelosa, K Ray Chaudhuri, Zuzana Walker, Federico E Turkheimer, David J Brooks. Neuropsychopharmacology 2013
150
27

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.
T Tokuda, M M Qureshi, M T Ardah, S Varghese, S A S Shehab, T Kasai, N Ishigami, A Tamaoka, M Nakagawa, O M A El-Agnaf. Neurology 2010
341
27

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Alexander Gerhard, Nicola Pavese, Gary Hotton, Federico Turkheimer, Meltem Es, Alexander Hammers, Karla Eggert, Wolfgang Oertel, Richard B Banati, David J Brooks. Neurobiol Dis 2006
753
27

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson's Disease.
Maria Antonietta Casu, Ignazia Mocci, Raffaella Isola, Augusta Pisanu, Laura Boi, Giovanna Mulas, Nigel H Greig, Maria Dolores Setzu, Anna R Carta. Front Aging Neurosci 2020
9
33

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia.
Andis Klegeris, Steven Pelech, Benoit I Giasson, John Maguire, Hong Zhang, Edith G McGeer, Patrick L McGeer. Neurobiol Aging 2008
161
27

MPTP mouse models of Parkinson's disease: an update.
Gloria E Meredith, David J Rademacher. J Parkinsons Dis 2011
258
18

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Jeffrey H Kordower, C Warren Olanow, Hemraj B Dodiya, Yaping Chu, Thomas G Beach, Charles H Adler, Glenda M Halliday, Raymond T Bartus. Brain 2013
653
18

Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
Zaodung Ling, Qin A Chang, Chong Wai Tong, Susan E Leurgans, Jack W Lipton, Paul M Carvey. Exp Neurol 2004
96
18

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Veronica Francardo, Alessandra Recchia, Nataljia Popovic, Daniel Andersson, Hans Nissbrandt, M Angela Cenci. Neurobiol Dis 2011
119
18

alpha-Synuclein locus triplication causes Parkinson's disease.
A B Singleton, M Farrer, J Johnson, A Singleton, S Hague, J Kachergus, M Hulihan, T Peuralinna, A Dutra, R Nussbaum,[...]. Science 2003
18

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.
Mathieu Bourdenx, Sandra Dovero, Michel Engeln, Simone Bido, Matthieu F Bastide, Nathalie Dutheil, Isabel Vollenweider, Laetitia Baud, Camille Piron, Virginie Grouthier,[...]. Acta Neuropathol Commun 2015
70
18

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
765
18

α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
W Peelaerts, L Bousset, A Van der Perren, A Moskalyuk, R Pulizzi, M Giugliano, C Van den Haute, R Melki, V Baekelandt. Nature 2015
726
18


Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.
Daniela Berg, Ronald B Postuma, Bastiaan Bloem, Piu Chan, Bruno Dubois, Thomas Gasser, Christopher G Goetz, Glenda M Halliday, John Hardy, Anthony E Lang,[...]. Mov Disord 2014
290
18

Animal models of neurological deficits: how relevant is the rat?
M Angela Cenci, Ian Q Whishaw, Timothy Schallert. Nat Rev Neurosci 2002
334
18

Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
R Betarbet, T B Sherer, G MacKenzie, M Garcia-Osuna, A V Panov, J T Greenamyre. Nat Neurosci 2000
18

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Hemraj B Dodiya, Christopher B Forsyth, Robin M Voigt, Phillip A Engen, Jinal Patel, Maliha Shaikh, Stefan J Green, Ankur Naqib, Avik Roy, Jeffrey H Kordower,[...]. Neurobiol Dis 2020
94
18

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.
Marie-Christine Chartier-Harlin, Jennifer Kachergus, Christophe Roumier, Vincent Mouroux, Xavier Douay, Sarah Lincoln, Clotilde Levecque, Lydie Larvor, Joris Andrieux, Mary Hulihan,[...]. Lancet 2004
18

Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.
Stephanie Janezic, Sarah Threlfell, Paul D Dodson, Megan J Dowie, Tonya N Taylor, Dawid Potgieter, Laura Parkkinen, Steven L Senior, Sabina Anwar, Brent Ryan,[...]. Proc Natl Acad Sci U S A 2013
186
18

Parkinson's disease: animal models and dopaminergic cell vulnerability.
Javier Blesa, Serge Przedborski. Front Neuroanat 2014
295
18

The 6-hydroxydopamine model of Parkinson's disease.
Nicola Simola, Micaela Morelli, Anna R Carta. Neurotox Res 2007
241
18

A highly reproducible rotenone model of Parkinson's disease.
Jason R Cannon, Victor Tapias, Hye Mee Na, Anthony S Honick, Robert E Drolet, J Timothy Greenamyre. Neurobiol Dis 2009
447
18

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Günter U Höglinger, Jean Féger, Annick Prigent, Patrick P Michel, Karine Parain, Pierre Champy, Merle Ruberg, Wolfgang H Oertel, Etienne C Hirsch. J Neurochem 2003
232
18

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Kelvin C Luk, Victoria Kehm, Jenna Carroll, Bin Zhang, Patrick O'Brien, John Q Trojanowski, Virginia M-Y Lee. Science 2012
18

Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.
Martin Lundblad, Mickael Decressac, Bengt Mattsson, Anders Björklund. Proc Natl Acad Sci U S A 2012
206
18

iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.
David C Schöndorf, Massimo Aureli, Fiona E McAllister, Christopher J Hindley, Florian Mayer, Benjamin Schmid, S Pablo Sardi, Manuela Valsecchi, Susanna Hoffmann, Lukas Kristoffer Schwarz,[...]. Nat Commun 2014
331
18

iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.
Edsel M Abud, Ricardo N Ramirez, Eric S Martinez, Luke M Healy, Cecilia H H Nguyen, Sean A Newman, Andriy V Yeromin, Vanessa M Scarfone, Samuel E Marsh, Cristhian Fimbres,[...]. Neuron 2017
456
18

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.
Irene López González, Paula Garcia-Esparcia, Franc Llorens, Isidre Ferrer. Int J Mol Sci 2016
61
18

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach.
Cai-Yun Liu, Xu Wang, Chang Liu, Hong-Liang Zhang. Front Cell Neurosci 2019
64
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.